Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Gastrointestinal Disorders”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Not applicableEnrolling By InvitationNCT06041906
What this trial is testing

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Who this might be right for
Congenital Portosystemic ShuntCPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin 500
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Not applicableLooking for participantsNCT04880356
What this trial is testing

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

Who this might be right for
Inherited DiseaseRare DiseasesMetabolic Disease+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 100
Testing effectiveness (Phase 2)Study completedNCT00016445
What this trial is testing

Phase II Study of Growth Hormone in Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Utah 40
Large-scale testing (Phase 3)Study completedNCT00004467
What this trial is testing

Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen

Who this might be right for
Acute Liver Failure
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 173
Large-scale testing (Phase 3)Study completedNCT00004339
What this trial is testing

Study of Tetrathiomolybdate in Patients With Wilson Disease

Who this might be right for
Wilson Disease
National Center for Research Resources (NCRR) 90
Not applicableStudy completedNCT05793385
What this trial is testing

The Uncommon Complications of Meckel's Diverticulum

Who this might be right for
To Report the Rare Occurrence of Meckel's Diverticulum
Haramaya Unversity 4
Testing effectiveness (Phase 2)Study completedNCT00004810
What this trial is testing

Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
National Center for Research Resources (NCRR) 30
Not applicableStudy completedNCT00323167
What this trial is testing

Rare Genetic Disorders of the Breathing Airways

Who this might be right for
Kartagener SyndromeCystic FibrosisPseudohypoaldosteronism+1 more
University of North Carolina, Chapel Hill 367
Early research (Phase 1)Study completedNCT00004779
What this trial is testing

Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
National Center for Research Resources (NCRR) 12
Not applicableLooking for participantsNCT03740503
What this trial is testing

Genomic Investigation of Unusual Responders

Who this might be right for
CancerBreast CancerNon-small Cell Lung Cancer+8 more
University Health Network, Toronto 100
Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)UnknownNCT00004315
What this trial is testing

Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease

Who this might be right for
Cystic FibrosisGastrointestinal DiseasesCholestasis
National Center for Research Resources (NCRR) 20
Testing effectiveness (Phase 2)Study completedNCT00004789
What this trial is testing

Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 59
Not applicableUnknownNCT05696912
What this trial is testing

Functional Tests to Resolve Unsolved Rare Diseases. Rares.

Who this might be right for
Intellectual DisabilityRubinstein-Taybi SyndromeCystic Fibrosis+4 more
University Hospital, Bordeaux 50
Large-scale testing (Phase 3)Looking for participantsNCT06988475
What this trial is testing

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

Who this might be right for
Solid TumourHaematological MalignancyMalignant Neoplasm+8 more
Cancer Research UK 30
Not applicableStudy completedNCT00004441
What this trial is testing

Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Children's Hospital Medical Center, Cincinnati 39
Not applicableUnknownNCT03283527
What this trial is testing

Organoid Based Response Prediction in Esophageal Cancer

Who this might be right for
OrganoidEsophageal CancerChemoradiation
University Medical Center Groningen 100
Testing effectiveness (Phase 2)Study completedNCT01833832
What this trial is testing

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma

Who this might be right for
Adrenocortical CarcinomaPeritoneal Carcinomatosis
National Cancer Institute (NCI) 11
Post-approval studies (Phase 4)Looking for participantsNCT07142343
What this trial is testing

Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease

Who this might be right for
CHAPLE Disease
Regeneron Pharmaceuticals 5
Load More Results